AIM ImmunoTech Inc. (AIMI)
OTCMKTS
· Delayed Price · Currency is USD
0.0400
+0.0100 (33.33%)
Apr 17, 2025, 4:00 PM EDT
AIM ImmunoTech Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 0.17 | 0.2 | 0.14 | 0.14 | 0.16 | Upgrade
|
| Revenue Growth (YoY) | -15.84% | 43.26% | 4.44% | -17.18% | 16.43% | Upgrade
|
| Cost of Revenue | 0.03 | 0.04 | - | 0.85 | 0.81 | Upgrade
|
| Gross Profit | 0.14 | 0.16 | 0.14 | -0.72 | -0.64 | Upgrade
|
| Selling, General & Admin | 14.16 | 21.64 | 13.29 | 8.67 | 8.65 | Upgrade
|
| Research & Development | 5.75 | 10.44 | 6.77 | 7.67 | 5.56 | Upgrade
|
| Operating Expenses | 19.91 | 32.08 | 20.06 | 16.34 | 14.22 | Upgrade
|
| Operating Income | -19.77 | -31.92 | -19.92 | -17.06 | -14.86 | Upgrade
|
| Interest Expense | -0.59 | - | - | -0.07 | -0.67 | Upgrade
|
| Interest & Investment Income | 5.19 | 1.07 | 0.63 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -2.06 | 1.67 | 1.53 | 2.46 | 1.06 | Upgrade
|
| EBT Excluding Unusual Items | -17.23 | -29.18 | -17.77 | -14.66 | -14.47 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.09 | 0.2 | -1.68 | -0.2 | 0.22 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.02 | 0 | 0.22 | - | Upgrade
|
| Asset Writedown | - | - | - | -1.78 | -0.29 | Upgrade
|
| Other Unusual Items | - | - | - | -2.7 | 0.14 | Upgrade
|
| Pretax Income | -17.32 | -28.96 | -19.45 | -19.13 | -14.4 | Upgrade
|
| Net Income | -17.32 | -28.96 | -19.45 | -19.13 | -14.4 | Upgrade
|
| Net Income to Common | -17.32 | -28.96 | -19.45 | -19.13 | -14.4 | Upgrade
|
| Shares Outstanding (Basic) | 56 | 49 | 48 | 47 | 32 | Upgrade
|
| Shares Outstanding (Diluted) | 56 | 49 | 48 | 47 | 32 | Upgrade
|
| Shares Change (YoY) | 15.30% | 1.12% | 1.49% | 48.67% | 774.15% | Upgrade
|
| EPS (Basic) | -0.31 | -0.60 | -0.40 | -0.40 | -0.45 | Upgrade
|
| EPS (Diluted) | -0.31 | -0.60 | -0.40 | -0.40 | -0.45 | Upgrade
|
| Free Cash Flow | -14.91 | -21.27 | -16.19 | -14.01 | -10.39 | Upgrade
|
| Free Cash Flow Per Share | -0.27 | -0.44 | -0.34 | -0.30 | -0.33 | Upgrade
|
| Gross Margin | 81.77% | 79.21% | 100.00% | - | - | Upgrade
|
| Operating Margin | -11630.59% | -15800.00% | -14129.79% | -12636.30% | -9115.95% | Upgrade
|
| Profit Margin | -10188.24% | -14337.62% | -13790.78% | -14168.15% | -8834.36% | Upgrade
|
| Free Cash Flow Margin | -8768.24% | -10528.22% | -11485.11% | -10374.81% | -6374.23% | Upgrade
|
| EBITDA | -19.53 | -31.68 | -19.67 | -16.28 | -14.13 | Upgrade
|
| D&A For EBITDA | 0.25 | 0.24 | 0.26 | 0.78 | 0.73 | Upgrade
|
| EBIT | -19.77 | -31.92 | -19.92 | -17.06 | -14.86 | Upgrade
|
| Revenue as Reported | 0.17 | 0.2 | 0.14 | 0.14 | 0.16 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.